BioSpace News Archive

CARMAT presents positive interim results of the first part of its PIVOTAL study

CARMAT today announced an update on its clinical progress and recent developments, as well as its cash position at December 31, 2018.

January 15, 2019
·
8 min read
Business

Lonza Announces Retirement of Fridtjof Helemann

Fridtjof Helemann will leave the company on 31 March 2019, upon reaching retirement age.

January 15, 2019
·
2 min read
Auris Medical Provides Update on Intranasal Betahistine Programs

Closes acquisition of Orphan Drug Designation for betahistine for the treatment of obesity associated with Prader-Willi syndrome (PWS)

January 15, 2019
·
5 min read
Medtronic Launches Mobile App That Communicates Directly with World’s First Smartphone-Connected Pacemakers

MyCareLink Heart(TM) Mobile App Allows Pacemaker Patients to Easily Stay Connected with Their Clinics

January 15, 2019
·
4 min read
Business

MD Anderson Cancer Center and Dragonfly Therapeutics announce strategic collaboration to take new immunotherapy candidates into clinical trials

The University of Texas MD Anderson Cancer Centerand Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly’s TriNKET™ (tri-specific natural killer cell engager therapy) immunotherapy drug candidates to patients in clinical trials beginning in 2019.

January 15, 2019
·
2 min read
Business

Auditdata A/S appoints new leadership

Auditdata announces that founder and CEO of Auditdata will step down and incoming CEO Kurt Bager will take over at the end of January 2019

January 15, 2019
·
2 min read
Job Trends

Complication rates and costs of invasive lung cancer diagnostic tests may be higher than anticipated

Study underscores importance of sharing risks with patients considering lung cancer screening

January 15, 2019
·
5 min read
Genetown

New LabElite® DeCapper SL Expands Hamilton Storage LabElite Product Family

Hamilton Storage introduces a new member of the LabElite® product family with the launch of the LabElite DeCapper SL

January 15, 2019
·
2 min read
Drug Development

Merck’s Keytruda Cuts Death Risk by 31% in Esophageal Cancer

Merck’s Keytruda just keeps on proving its value to the company and patients. The company released data from KEYNOTE-181, a Phase III trial of Keytruda as a monotherapy for the second-line treatment of advanced or metastatic esophageal or esophagogastric junction carcinoma.

January 15, 2019
·
3 min read
·
Mark Terry
FDA

Aimmune’s Peanut Allergy Treatment Delayed as Government Shutdown Continues

The partial government shutdown has entered day 24 and the pharma and medtech industry is beginning to feel the impact even more, particularly as the U.S. Food and Drug Administration grows more incapable of reviewing some medications for approval.

January 15, 2019
·
2 min read
·
Alex Keown